Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients

NCT04729517 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis Due to Allergens

Interventions

DRUG: AI201901
DRUG: Azelastine Hydrochloride

Sponsor

Abdi Ibrahim Ilac San. ve Tic A.S.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]